The increasing prevalence of cardiac arrhythmias and availability of premium-priced innovative technologies are driving the cardiac ablation market in the United States. Promising technologies – including balloon-based ablation catheters such as cryo-balloons, visually-guided lasers, and radiofrequency balloons – will push the market forward. Image-guidance and mapping technologies are currently under development, some of which are predicted to usher in a new era of effective and personalized atrial fibrillation (AF) care management.
Source: Frost & Sullivan Analysis of the U.S. Cardiac Ablation Market; www.frost.com
Explore the August 2014 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Best of 2024: #9 Article – Strategy Milling combines old and new for precision dental restorations
- Best of 2024: #9 News – Global robotics race
- Best of 2024: #10 Article – Designing medical devices for every user
- Best of 2024: #10 News – 4 predictions for 2024: AI set to supercharge robotic automation
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology